Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 9167450, 10 pages
https://doi.org/10.1155/2017/9167450
Research Article

miR-503 Is Involved in the Protective Effect of Phase II Enzyme Inducer (CPDT) in Diabetic Cardiomyopathy via Nrf2/ARE Signaling Pathway

Department of Endocrinology, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China

Correspondence should be addressed to Qin Wan; moc.361@3niqnaw

Received 22 August 2017; Revised 8 October 2017; Accepted 25 October 2017; Published 18 December 2017

Academic Editor: Osamu Handa

Copyright © 2017 Ying Miao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Voulgari, D. Papadogiannis, and N. Tentolouris, “Diabetic cardiomyopathy: From the pathophysiology of the cardiac myocytes to current diagnosis and management strategies,” Vascular Health and Risk Management, vol. 6, no. 1, pp. 883–903, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Di Luigi, C. Corinaldesi, M. Colletti et al., “Phosphodiesterase type 5 inhibitor sildenafil decreases the proinflammatory chemokine CXCL10 in human cardiomyocytes and in subjects with diabetic cardiomyopathy,” Inflammation, vol. 39, no. 3, pp. 1238–1252, 2016. View at Publisher · View at Google Scholar
  3. Y. Kayama, U. Raaz, A. Jagger et al., “Diabetic cardiovascular disease induced by oxidative stress,” International Journal of Molecular Sciences, vol. 16, no. 10, pp. 25234–25263, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Ni, D. Zheng, and S. Xiong, “Mitochondrial calpain-1 disrupts ATP synthase and induces superoxide generation in type-1 diabetic hearts: a novel mechanism contributing to diabetic cardiomyopathy,” Diabetes, vol. 65, no. 1, pp. 255–268, 2016. View at Publisher · View at Google Scholar
  5. R. Munday, Y. Zhang, C. M. Munday, and J. Li, “Structure-activity relationships in the induction of Phase II enzymes by derivatives of 3H-1,2-dithiole-3-thione in rats,” Chemico-Biological Interactions, vol. 160, no. 2, pp. 115–122, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Wang, M. Wang, J. Hu et al., “Protective effect of 3H-1, 2-dithiole-3-thione on cellular model of Alzheimer's disease involves Nrf2/ARE signaling pathway,” European Journal of Pharmacology, vol. 795, pp. 115–123, 2017. View at Publisher · View at Google Scholar · View at Scopus
  7. Z. Feng, Z. Liu, X. Li et al., “α-Tocopherol is an effective Phase II enzyme inducer: Protective effects on acrolein-induced oxidative stress and mitochondrial dysfunction in human retinal pigment epithelial cells,” The Journal of Nutritional Biochemistry, vol. 21, no. 12, pp. 1222–1231, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. J. E. Cohen, P. R. Lee, S. Chen, W. Li, and R. D. Fields, “MicroRNA regulation of homeostatic synaptic plasticity,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 108, no. 28, pp. 11650–11655, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Krol, I. Loedige, and W. Filipowicz, “The widespread regulation of microRNA biogenesis, function and decay,” Nature Reviews Genetics, vol. 11, no. 9, pp. 597–610, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Cai, T. Yang, X. Jiang, M. Zheng, G. Xu, and J. Xia, “Role of miR-15a in intervertebral disc degeneration through targeting MAP3K9,” Biomedicine & Pharmacotherapy, vol. 87, pp. 568–574, 2017. View at Publisher · View at Google Scholar · View at Scopus
  11. R. G. Wallace, L. C. Twomey, M.-A. Custaud et al., “Potential Diagnostic and Prognostic Biomarkers of Epigenetic Drift within the Cardiovascular Compartment,” BioMed Research International, vol. 2016, Article ID 2465763, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. X. H. Wang, R. Z. Qian, W. Zhang, S. F. Chen, H. M. Jin, and R. M. Hu, “MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats,” Clinical and Experimental Pharmacology & Physiology, vol. 36, no. 2, pp. 181–188, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Pescador, M. Perez-Barba, J. M. Ibarra, A. Corbaton, M. T. Martinez-Larrad, and M. Serrano-Rios, “Serum circulating microRNA profiling for identification of potential type 2 diabetes and obesity biomarkers,” PLoS ONE, vol. 8, no. 10, Article ID e77251, 2013. View at Publisher · View at Google Scholar
  14. X. Li, N. Du, and Q. Zhang, “MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy,” Cell Death & Disease, vol. 5, no. 10, Article ID e1479, 2014. View at Publisher · View at Google Scholar
  15. M. Enomoto, T. Ishizu, Y. Seo et al., “Subendocardial systolic dysfunction in asymptomatic normotensive diabetic patients,” Circulation Journal, vol. 79, no. 8, pp. 1749–1755, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Hodzic, V. Ribault, P. Maragnes, P. Milliez, E. Saloux, and F. Labombarda, “Decreased regional left ventricular myocardial strain in type 1 diabetic children: a first sign of diabetic cardiomyopathy?” Journal of Translational Internal Medicine, vol. 4, no. 2, pp. 81–87, 2016. View at Publisher · View at Google Scholar
  17. D. Suran, A. Sinkovic, and F. Naji, “Tissue Doppler imaging is a sensitive echocardiographic technique to detect subclinical systolic and diastolic dysfunction of both ventricles in type 1 diabetes mellitus,” BMC Cardiovascular Disorders, vol. 16, no. 1, article no. 72, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Drechsler, S. Kalim, J. B. Wenger et al., “Protein carbamylation is associated with heart failure and mortality in diabetic patients with end-stage renal disease,” Kidney International, vol. 87, no. 6, pp. 1201–1208, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Rajesh, S. Bátkai, M. Kechrid et al., “Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy,” Diabetes, vol. 61, no. 3, pp. 716–727, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Rajesh, P. Mukhopadhyay, S. Btkai et al., “Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy,” Journal of the American College of Cardiology, vol. 56, no. 25, pp. 2115–2125, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. Z.-G. Ma, Y.-P. Yuan, S.-C. Xu et al., “CTRP3 attenuates cardiac dysfunction, inflammation, oxidative stress and cell death in diabetic cardiomyopathy in rats,” Diabetologia, vol. 60, no. 6, pp. 1126–1137, 2017. View at Publisher · View at Google Scholar · View at Scopus
  22. Z. Li, C. S. Abdullah, and Z. Jin, “Inhibition of PKC-θ preserves cardiac function and reduces fibrosis in streptozotocin-induced diabetic cardiomyopathy,” British Journal of Pharmacology, vol. 171, no. 11, pp. 2913–2924, 2014. View at Publisher · View at Google Scholar
  23. V. Soetikno, F. R. Sari, V. Sukumaran et al., “Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: possible involvement of PKC-MAPK signaling pathway,” European Journal of Pharmaceutical Sciences, vol. 47, no. 3, pp. 604–614, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. X.-Y. Liu, C.-Y. Li, H. Bu et al., “The neuroprotective potential of phase II enzyme inducer on motor neuron survival in traumatic spinal cord injury in vitro,” Cellular and Molecular Neurobiology, vol. 28, no. 5, pp. 769–779, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. X.-Y. Liu, C.-Y. Li, H. Bu et al., “Neuroprotective effect of CPDT on THA-induced cortical motor neuron death in an organotypic culture model,” Brain Research Bulletin, vol. 83, no. 6, pp. 345–350, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. J. D. Paonessa, Y. Ding, K. L. Randall et al., “Identification of an unintended consequence of Nrf2-directed cytoprotection against a key tobacco carcinogen plus a counteracting chemopreventive intervention,” Cancer Research, vol. 71, no. 11, pp. 3904–3911, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Cong, S. Xiao, Y. Chen et al., “Integrated miRNA and mRNA transcriptomes of porcine alveolar macrophages (PAM cells) identifies strain-specific miRNA molecular signatures associated with H-PRRSV and N-PRRSV infection,” Molecular Biology Reports, vol. 41, no. 9, pp. 5863–5875, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. M. P. LaPierre and M. Stoffel, “MicroRNAs as stress regulators in pancreatic beta cells and diabetes,” Molecular Metabolism, vol. 6, no. 9, pp. 1010–1023, 2017. View at Publisher · View at Google Scholar
  29. A. Dorner, K. Schulze, U. Rauch, and H. P. Schultheiss, “Adenine nucleotide translocator in dilated cardiomyopathy: pathophysiological alterations in expression and function,” Molecular and Cellular Biochemistry, vol. 174, pp. 261–269, 1997. View at Google Scholar
  30. X. Hu, T. Bai, Z. Xu, Q. Liu, Y. Zheng et al., “Pathophysiological fundamentals of diabetic cardiomyopathy,” Comprehensive Physiology, vol. 7, pp. 693–711, 2017. View at Google Scholar
  31. K. Lu, A. L. Alcivar, J. Ma et al., “NRF2 Induction Supporting Breast Cancer Cell Survival Is Enabled by Oxidative Stress–Induced DPP3–KEAP1 Interaction,” Cancer Research, vol. 77, no. 11, pp. 2881–2892, 2017. View at Publisher · View at Google Scholar
  32. M. H. Lee, M. H. Han, D.-S. Lee et al., “Morin exerts cytoprotective effects against oxidative stress in C2C12 myoblasts via the upregulation of Nrf2-dependent HO-1 expression and the activation of the ERK pathway,” International Journal of Molecular Medicine, vol. 39, no. 2, pp. 399–406, 2017. View at Publisher · View at Google Scholar · View at Scopus
  33. Z. Xu, J. Sun, Q. Tong et al., “The role of ERK1/2 in the development of diabetic cardiomyopathy,” International Journal of Molecular Sciences, vol. 17, no. 12, article no. 2001, 2016. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Umbarkar, S. Singh, S. Arkat, S. L. Bodhankar, S. Lohidasan, and S. L. Sitasawad, “Monoamine oxidase-A is an important source of oxidative stress and promotes cardiac dysfunction, apoptosis, and fibrosis in diabetic cardiomyopathy,” Free Radical Biology & Medicine, vol. 87, pp. 263–273, 2015. View at Publisher · View at Google Scholar
  35. Y. Zhu, Y.-J. Zhang, W.-W. Liu, A.-W. Shi, and N. Gu, “Salidroside suppresses HUVECs cell injury induced by oxidative stress through activating the Nrf2 signaling pathway,” Molecules, vol. 21, no. 8, article no. 1033, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. C. Hseu, C. W. Chou, K. J. Senthil Kumar et al., “Ellagic acid protects human keratinocyte (HaCaT) cells against UVA-induced oxidative stress and apoptosis through the upregulation of the HO-1 and Nrf-2 antioxidant genes,” Food and Chemical Toxicology, vol. 50, no. 5, pp. 1245–1255, 2012. View at Publisher · View at Google Scholar · View at Scopus